Clinical utility of insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels in the diagnosis of GH deficiency (GHD) during childhood

Endocrine Journal

Volumn 43, Issue SUPPL., 1996, Pages

  Hasegawa, Yukihiro ^a,c   Hasegawa, Tomonobu ^b   Anzo, Makoto ^a   Aso, Taiji ^a   Tsuchiya, Yutaka ^b  

^a Div of Endocrinology and Metabolism   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c Div of Endocrinology and Metabolism   (Japan)

Author keywords

GH deficiency; GH secretion; IGF binding protein 3; Insulin like growth factor I (IGF I)

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACROMEGALY; ARTICLE; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; PROVOCATION TEST; SHORT STATURE;

EID: 0030471477     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.43.suppl_s1     Document Type: Article

References (9)

1. Hasegawa Y, Hasegawa T, Tsuchiya Y (1995) Clinical utility of total insulin-like growth factor-I and insulin-like growth factor binding protein-3 measurements in the evaluation of short children. Clin Pediatr Endocrinol 4 (2); 103-113.
2. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, Frasier SD, Hasegawa Y, Hintz RL, Lafranchi S, Lippe B, Loriaux L, Melmed S, Preece MA, Ranke MB, Reiter EO, Rogol AD, Underwood LE, Werther GA (1995) Diagnostic controversy; the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 80: 1532-1540.
3. Suwa S, Tachibana K, Maesaka H, Tanaka T, Yokoya S (1992) Longitudinal standards for height and height velocity for Japanese children from birth to maturity. Clin Pediatr Endocrinol 1: 5-11.
4. Hasegawa Y, Hasegawa T, Kotoh S, Tsuchiya Y (1993) Ratio of false positive results of GH provocation tests (arginine and insulin) in control and normal short children. Clin Pediatr Endocrinol 2 (suppl): 65-67.
5. Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Nose O, Ohyama Y (1994) Clinical utility of insulin-like growth factor-binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency. Eur J Endocrinol 131: 27-32.
6. Martin G, Domene HM, Barnes KM, Blackwell BJ, Cassorla FG, Cutler Jr GB (1994) The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 79: 537-541.
7. Takada M, Nakanome H, Kishida M, Hirose S, Hasegawa T, Hasegawa Y (1994) Measurements of free IGF-I using immunoradiometric assay. J Immunoassay 15(3): 263-276.
8. Hasegawa Y, Hasegawa T, Takada M, Tsuchiya Y (1996) Plasma free insulin-like growth factor I concentrations in growth hormone deficiency in children and adolescents. Eur J Endocrinol 34: 184-189.
9. Baxter RC (1990) Circulating levels and molecular distribution of the acid-labile subunit of th high molecular weight insulin-like growth factor-binding protein complex. J Clin Endocrinol Metab 70: 1347-1353.